Search Saint Luke's

Dr. Timothy Bateman spoke with Cardiovascular Business about his group's findings and what it is like to work with flurpiridaz.

Percutaneous coronary intervention is associated with significant short-term improvements in high-risk patients with complex coronary artery disease who are ineligible for coronary artery bypass grafting, according to a new analysis.

Dr. Andrew Sauer wrote an editorial on a newly published study that found more than one in four cardiologists experience mental health conditions.

In 2021, Saint Luke’s launched its heart team-led Wound Transition Program, which went on to surpass national goals and cut PAD amputation rates in half.

Semaglutide improves symptoms in both men and women who present with heart failure. When it comes to weight loss, however, the drug appears to benefit women much more than men.

Cardiovascular Business spoke with Dr. Timothy Bateman about his views on SPECT advances and its longevity in the coming years.

TAVR in asymptomatic and minimally symptomatic patients is associated with a high survival rate, but relatively minor improvements, according to new research.

Rehospitalization after aortic valve replacement (AVR) is associated with an increased risk of patient mortality, according to new research.

Fellows at the University of Missouri-Kansas City School of Medicine and Saint Luke’s are mentored by national and international leaders in the cardiology field. Our primary training site is Saint Luke's Mid America Heart Institute, located at Saint Luke's Hospital of Kansas City near the Country Club Plaza.

Saint Luke’s Mid America Heart Institute cardiovascular disease fellowship rotations allow for balance and flexibility within the program.